CV Sciences (CVSI) EPS (Weighted Average and Diluted) (2017 - 2026)

CV Sciences has disclosed EPS (Weighted Average and Diluted) across 10 years of filings, most recently posting -$0.0 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.0, down 481.53% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.01 (up 1.73% YoY), and the FY2025 annual result was -$0.01, changed 0.0% from the prior year.
• EPS (Weighted Average and Diluted) came in at -$0.0 for Q1 2026 at CV Sciences, up from -$0.01 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.04 in Q1 2023 to a low of -$0.03 in Q2 2022.
• The 5-year median for EPS (Weighted Average and Diluted) is -$0.0 (2024), against an average of -$0.01.
• Across the five-year window, EPS (Weighted Average and Diluted) plunged 2577.48% in 2022 and jumped 300.0% in 2023, its largest moves.
• CV Sciences' EPS (Weighted Average and Diluted) stood at -$0.02 in 2022, then soared by 50.0% to -$0.01 in 2023, then soared by 58.65% to -$0.0 in 2024, then tumbled by 141.85% to -$0.01 in 2025, then surged by 65.6% to -$0.0 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.0 (Q1 2026), -$0.01 (Q4 2025), and -$0.0 (Q3 2025), per Business Quant data.